Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Nurofen (NSAID)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nurofen Express 400mg liquid capsules
1001010J0B4AVAU
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 224 |
|
Nurofen Meltlets 200mg tablets
1001010J0B4AHBN
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 168 |
|
Nurofen Plus tablets
1001010J0B4AKAY
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 154 |
|
Nurofen for Children 100mg/5ml oral suspension orange
1001010J0B4AJBH
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 144 |
|
Nurofen for Children 100mg/5ml oral suspension strawberry
1001010J0B4AQBH
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 140 |
|
Nurofen Express 200mg liquid capsules
1001010J0B4AUAA
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 78 |
|
Nurofen for Children 200mg/5ml oral suspension strawberry
1001010J0B4BDBR
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 28 |
|
Nurofen for Children 200mg/5ml oral suspension orange
1001010J0B4BCBR
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 24 |
|
Nurofen Long Lasting Pain Relief PR 300mg capsules
1001010J0B4ANAB
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 23 |
|
Nurofen for Child Cold, Pain & Fever Orange 100mg/5ml susp
1001010J0B4AYBH
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 9 |
|
Nurofen Pain Relief 200mg capsules
1001010J0B4AZAA
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 8 |
|
Nurofen for Child Cold, Pain & Fever S/berry 100mg/5ml susp
1001010J0B4AXBH
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 7 |
|
Nurofen for Children 100mg chewable capsules
1001010J0B4BBBQ
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 2 |
|
Nurofen Cold and Flu tablets
1001010J0B4APBJ
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 1 |
|
Nurofen for Children Singles 100mg/5ml susp 5ml sach orange
1001010J0B4ALBM
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 1 |
|
Nurofen 200mg caplets
1001010J0B4AEAD
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen 200mg liquid capsules
1001010J0B4AIAA
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen 200mg tablets
1001010J0B4ABAD
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen Express Period Pain 200mg capsules
1001010J0B4AWAA
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen Extra Strength 400mg capsules
1001010J0B4ATAU
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen for Children Singles 100mg/5ml susp 5ml strawberry
1001010J0B4ARBM
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen Long Lasting 300mg capsules
1001010J0B4AGAB
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen Recovery 200mg orodispersible tablets
1001010J0B4AMBN
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen Sinus Pressure & Headache Relief 200mg/30mg tablets
1001010J0B4BABJ
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen Sinus tablets
1001010J0B4ASBJ
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.